Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Exp Physiol. 2008 Feb 22;93(7):817–824. doi: 10.1113/expphysiol.2008.042085

Figure 1. Plasma aldosterone (A), renal aldosterone (B), representative renal aldosterone synthase (CYP11B2) mRNA (C, upper panel) and protein (C, lower panel), blood glucose (D) and urinary albumin excretion (E) in adrenalectomized (ADX) normoglycaemic (ADX control), adrenalectomized diabetic (ADX + Diabetes) and adrenalectomized diabetic rats treated with the aldosterone synthase inhibitor FAD286 (ADX + Diabetes + FAD286).

Figure 1

* P < 0.01 from control; **P < 0.01 from control or ADX + Diabetes. n = 8 each group.